An elevated PSA level in the blood may indicate prostate cancer but does not allow for a definitive diagnosis. Where there is a corresponding suspicion, a tissue sample is usually taken from the ...

A case report led by UCLA Health researchers highlights the importance of a multidisciplinary, evidence-based approach to ...

A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium fluoride (Na-F-18) positron emission tomography/computed tomography (NaF-PET/CT) accurately detects ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

A 5-year OS rate of 97.1% was observed among patients who received PSMA PET/CT restaging at first biochemical recurrence following prostatectomy. The inclusion of prostate-specific membrane antigen ...

Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.

Newswise — A five-year retrospective study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center and published in the Journal of the National Comprehensive Cancer Network shows ...

Add Yahoo as a preferred source to see more of our stories on Google. The scan works by using a molecule that binds to prostate cancer cells, causing them to appear as bright spots on imaging A scan ...

A 58-year-old businessman walks into a clinic for a routine health check. He feels fine. No pain, no urinary trouble, nothing ...

A new term has come for metastatic prostate cancer treatment at Fox Chase Cancer Center. 'Theranostics' combines diagnostics ...